Neurology
Participate in Alzheimer’s Disease Clinical Trials Focused on Improving Symptoms of Alzheimer’s Disease Psychosis
Alzheimer’s Disease Research
Clinical Trials for Alzheimer's Disease in Los Angeles
Watching a loved one experience Alzheimer’s disease can be emotionally challenging, especially when symptoms such as hallucinations and delusions affect their sense of reality, independence, and daily interactions. These symptoms of Alzheimer’s disease psychosis can create distress for both patients and caregivers.
Zillan Clinical Research is conducting Phase II Alzheimer’s disease clinical trials evaluating the safety and effectiveness of an investigational therapy for adults aged 55 to 90 living with hallucinations and delusions associated with Alzheimer’s disease psychosis. Eligible participants may receive study-related care, cognitive and behavioural assessments, and close monitoring throughout the study, without any cost.
Exploring New Possibilities in Alzheimer's Disease Psychosis Care
When hallucinations and delusions appear alongside Alzheimer’s disease, they can make daily life confusing and frightening, not just for the person experiencing them, but for the loved ones supporting them. Despite ongoing memory loss clinical trials and broader Alzheimer’s disease research, this specific symptom cluster remains one of the most challenging aspects of the disease to manage.
These Alzheimer’s disease clinical trials at Zillan Clinical Research are evaluating the efficacy and safety of the study drug, measured through clinical assessment of hallucination and delusion severity. Eligible participants receive close monitoring from our clinical team throughout the study.
Now Enrolling
Psychosis Associated With Alzheimer's Disease
Phase II
Phase
Why Patients Trust Us
Integrity
Patient Safety
Scientific Excellence
Innovation
Diversity & Inclusion
Trusted Oversight
FAQ
Frequently Asked Questions
What are Alzheimer's disease clinical trials?
Alzheimer's disease clinical trials are research studies evaluating new investigational treatments for symptoms related to Alzheimer's disease, including cognitive decline and associated psychiatric symptoms such as hallucinations and delusions.
What is this Alzheimer's disease research study evaluating?
This study is evaluating an investigational medication for its effectiveness and safety in treating hallucinations and delusions associated with Alzheimer's Disease Psychosis.
Who is eligible to join?
Adults aged 55 to 90 who have Alzheimer's disease and are experiencing hallucinations and/or delusions may be eligible. A member of our clinical team will review your full medical history during the eligibility screening process.
What happens during Alzheimer's disease clinical trials?
Participants undergo structured study visits, clinical assessments, and safety monitoring throughout the trial. A caregiver or family member's involvement may also be part of the process to help support the participant.
What is this study looking to achieve?
The study aims to determine whether the study drug can meaningfully reduce hallucinations and delusions in patients living with Alzheimer's disease, compared with placebo.
Are there ongoing memory loss clinical trials in Los Angeles?
Yes, Zillan Clinical Research conducts a range of studies addressing different aspects of Alzheimer's disease, including memory loss and associated psychiatric symptoms, at our Los Angeles location.
Is participation in Alzheimer's disease clinical trials safe?
All studies follow strict clinical guidelines, with close monitoring by qualified professionals to ensure participant safety and comfort throughout the process.
Still have questions? Our team is here to support you with your clinical research needs.
Join Us
Supporting Innovation
Through Structured Clinical Trials
Join studies designed to advance medical knowledge and support the development of next-generation therapies.
